Carregant...
Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
Triple-Negative Breast Cancer (TNBC), represents a subtype of breast cancer in which the estrogens receptor (ER) negative, the progesterone receptor (PR) negative and the human epidermal growth factor receptor 2 (HER2) negative, are not expressed. Thusly, TNBC does not respond to hormonal therapies...
Guardat en:
| Publicat a: | Infect Agent Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954554/ https://ncbi.nlm.nih.gov/pubmed/31938038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-020-0270-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|